Cargando…
Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery
BACKGROUND: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised contr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589068/ https://www.ncbi.nlm.nih.gov/pubmed/26425342 http://dx.doi.org/10.1186/s13741-015-0019-7 |
_version_ | 1782392738699804672 |
---|---|
author | Li, N. Statkevicius, S. Asgeirsson, B. Schött, U. |
author_facet | Li, N. Statkevicius, S. Asgeirsson, B. Schött, U. |
author_sort | Li, N. |
collection | PubMed |
description | BACKGROUND: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure—not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the “Lund concept” of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy. METHODS: Thirty-nine patients undergoing elective brain tumour surgery with craniotomy received either 130/0.42 hydroxyethyl starch or 5 % albumin infusions. The first 18 patients received starch, whereas the rest received albumin. Rotational thromboelastometry with ROTEM and platelet aggregometry with Multiplate were performed before surgery, after the first and second consecutive colloid infusions (250/500 ml albumin or 500/1000 ml starch) and at the end of surgery. RESULTS: Both intra- and inter-group comparisons showed more deranged ROTEM parameters after the higher doses of starch. Multiplate detected changes only in the albumin group after 500-ml infusion. Blood los did not differ between groups, nor did haemoglobin preoperatively or at end of surgery. Lower volumes of albumin were required to maintain stable intra-operative haemodynamic parameters; 250/500 ml albumin corresponded to 500/1000 ml starch. CONCLUSIONS: Hydroxyethyl starch affected coagulation at lower volumes, with a more prominent effect on clot structure at the end of surgery, corroborating previous research. Only albumin decreased platelet aggregation, and 5 % albumin had a more potential volume effect than 130/0.42 hydroxyethyl starch. |
format | Online Article Text |
id | pubmed-4589068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45890682015-10-01 Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery Li, N. Statkevicius, S. Asgeirsson, B. Schött, U. Perioper Med (Lond) Research BACKGROUND: The European Medicines Agency does not recommend the use of hydroxyethyl starch-based volume replacement solutions in critically ill patients due to an increased risk of renal failure. However, this recommendation is questionable for its perioperative use. Several recent randomised controlled studies do not indicate a risk for renal failure—not even after high-risk surgery. Human albumin is used in our neurointensive care unit as a part of the “Lund concept” of brain injury resuscitation, and albumin has been introduced in elective neurosurgery instead of starch. The aim of our prospective unblinded observational cohort study was to compare the degree of dilutive coagulopathy after albumin and starch intra-operative fluid therapy. METHODS: Thirty-nine patients undergoing elective brain tumour surgery with craniotomy received either 130/0.42 hydroxyethyl starch or 5 % albumin infusions. The first 18 patients received starch, whereas the rest received albumin. Rotational thromboelastometry with ROTEM and platelet aggregometry with Multiplate were performed before surgery, after the first and second consecutive colloid infusions (250/500 ml albumin or 500/1000 ml starch) and at the end of surgery. RESULTS: Both intra- and inter-group comparisons showed more deranged ROTEM parameters after the higher doses of starch. Multiplate detected changes only in the albumin group after 500-ml infusion. Blood los did not differ between groups, nor did haemoglobin preoperatively or at end of surgery. Lower volumes of albumin were required to maintain stable intra-operative haemodynamic parameters; 250/500 ml albumin corresponded to 500/1000 ml starch. CONCLUSIONS: Hydroxyethyl starch affected coagulation at lower volumes, with a more prominent effect on clot structure at the end of surgery, corroborating previous research. Only albumin decreased platelet aggregation, and 5 % albumin had a more potential volume effect than 130/0.42 hydroxyethyl starch. BioMed Central 2015-09-29 /pmc/articles/PMC4589068/ /pubmed/26425342 http://dx.doi.org/10.1186/s13741-015-0019-7 Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, N. Statkevicius, S. Asgeirsson, B. Schött, U. Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery |
title | Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery |
title_full | Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery |
title_fullStr | Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery |
title_full_unstemmed | Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery |
title_short | Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery |
title_sort | effects of different colloid infusions on rotem and multiplate during elective brain tumour neurosurgery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589068/ https://www.ncbi.nlm.nih.gov/pubmed/26425342 http://dx.doi.org/10.1186/s13741-015-0019-7 |
work_keys_str_mv | AT lin effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery AT statkeviciuss effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery AT asgeirssonb effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery AT schottu effectsofdifferentcolloidinfusionsonrotemandmultiplateduringelectivebraintumourneurosurgery |